Calcium channel blocker use and gastrointestinal tract bleeding among older adults [1]

Age and Ageing

Volumn 31, Issue 3, 2002, Pages 217-218

  Kaplan, Robert C ^a   Heckbert, Susan R ^a   Koepsell, Thomas D ^a   Rosendaal, Frits R ^a   Furberg, Curt D ^a   Cooper, Lawton S ^a   Psaty, Bruce M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; NITRENDIPINE; PHENYLALKYLAMINE; PLACEBO;

AGE; AGED; ANAMNESIS; ANTICOAGULANT THERAPY; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; ERYTHROCYTE DEFORMABILITY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; HYPOTHESIS; INCIDENCE; LETTER; MEDICAL RECORD; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK; THROMBOCYTE FUNCTION; UNITED STATES; VASODILATATION;

AGED; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; GASTROINTESTINAL HEMORRHAGE; GERIATRIC ASSESSMENT; HEALTH SERVICES FOR THE AGED; HUMANS; HYPERTENSION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036267997     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/31.3.217     Document Type: Letter

References (9)

1. Antagonism to calcium antagonists
2. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
3. Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding
4. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris
5. Cardiovascular diseases, blood rheology, and dihydropyridine calcium antagonists
6. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study
7. Surgical bleeding: Unexpected effect of a calcium antagonist
8. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
9. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension